A randomized clinical trial evaluating Hydralazine's efficacy in early-stage Alzheimer's disease: The EHSAN Study.
Mirzaei M, Ahmadi N, Bagheri Fahraji B, Ardekani AM, Rahimdel A, Soltani MH, Ardekani SMY, Bidaki R, Kasnavie FH, Dastjerdi G, Aboutorabi M, Mirzaei H.
Mirzaei M, et al.
Sci Rep. 2024 Nov 21;14(1):28837. doi: 10.1038/s41598-024-79616-4.
Sci Rep. 2024.
PMID: 39572624
Free PMC article.
Alzheimer's Disease (AD), a neurodegenerative disorder escalating worldwide, remains incurable with existing interventions merely mitigating symptoms. ...This trial will explore the potential benefits and risks of hydralazine in mild to moderate AD treatment. It's t …
Alzheimer's Disease (AD), a neurodegenerative disorder escalating worldwide, remains incurable with existing interventions merely mit …